Fici G J, Althaus J S, VonVoigtlander P F
CNS Diseases Research, Pharmacia and Upjohn Inc., Kalamazoo, MI 49001, USA.
Free Radic Biol Med. 1997;22(1-2):223-8. doi: 10.1016/s0891-5849(96)00296-1.
We developed a cerebellar granule cell model of peroxynitrite toxicity and showed that certain sulfhydryl-containing compounds (e.g., penicillamine) present as concurrent treatments could inhibit this toxicity. In the present study, 21-aminosteroid and pyrrolopyrimidine lazaroids were tested for cytoprotection in this peroxynitrite toxicity model. In addition, we tested for added protection using a peroxynitrite scavenger concurrent treatment combined with a lazaroid post-treatment. The toxicity assay utilized cells that were previously exposed to 100 microM L-buthionine (S,R)-sulfoximine (BSO), an inhibitor of gamma-glutamyl-cysteine synthetase, for 24 h. This sublethal concentration of BSO shifted the peroxynitrite (1-1000 microM) toxicity curve to the left by more than one-half of a log unit. The half-maximal toxicity concentration (TC50) of peroxynitrite in cells treated with BSO was 50 microM. The 21-aminosteroids, U-74006F and U-74500A, and the pyrrolopyrimidines, U-91736B and U-101033E, were tested as post-treatments. U-74006F and U-74500A had EC50 values of approximately 100 microM (concentrations which blocked 50% of the toxicity). U-91736B and U-101033E had EC50 values of 1 microM and showed 100% protection at 3-10 microM. Treatment with either 100 microM U-74006F or 1 microM U-101033E resulted in a right-hand shift (protection) in the peroxynitrite toxicity curve. Further, combination treatment of lazaroids with 1 mM penicillamine resulted in additive protection compared to either treatment alone.
我们建立了过氧亚硝酸盐毒性的小脑颗粒细胞模型,并表明作为联合治疗使用的某些含巯基化合物(如青霉胺)可以抑制这种毒性。在本研究中,对21-氨基类固醇和吡咯并嘧啶类拉扎罗ids在该过氧亚硝酸盐毒性模型中的细胞保护作用进行了测试。此外,我们测试了使用过氧亚硝酸盐清除剂联合治疗并结合拉扎罗ids后处理是否能增强保护作用。毒性试验使用的细胞先前已暴露于100微摩尔L-丁硫氨酸(S,R)-亚砜亚胺(BSO),一种γ-谷氨酰半胱氨酸合成酶抑制剂,持续24小时。这种亚致死浓度的BSO使过氧亚硝酸盐(1-1000微摩尔)毒性曲线向左移动了超过半个对数单位。用BSO处理的细胞中过氧亚硝酸盐的半数最大毒性浓度(TC50)为50微摩尔。测试了21-氨基类固醇U-74006F和U-74500A以及吡咯并嘧啶类U-91736B和U-101033E作为后处理药物。U-74006F和U-74500A的半数有效浓度(EC50)值约为100微摩尔(该浓度可阻断50%的毒性)。U-91736B和U-101033E的EC50值为1微摩尔,并在3-10微摩尔时显示出100%的保护作用。用100微摩尔U-74006F或1微摩尔U-101033E处理导致过氧亚硝酸盐毒性曲线向右移动(保护作用)。此外,与单独使用任一药物相比,拉扎罗ids与1毫摩尔青霉胺联合治疗产生了相加的保护作用。